» Articles » PMID: 30772440

Complementary Relation Between the Improvement of Dose Delivery Technique and PTV Margin Reduction in Dose-Escalated Radiation Therapy for Prostate Cancer

Overview
Publisher Elsevier
Specialties Oncology
Radiology
Date 2019 Feb 18
PMID 30772440
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this study is to demonstrate quantitatively the complementary relationship between the introduction of intensity modulated radiation therapy (IMRT) and planning target volume (PTV) margin reduction with an image guided technique in reducing the risk of rectal toxicity in dose-escalating prostate radiation therapy.

Methods And Materials: Three-dimensional conformal radiation therapy (CRT) and IMRT plans were generated for 10 patients with prostate cancer based on 2 PTV margin protocols (10/8 mm and 6/5 mm) and 2 dose prescriptions (70 Gy and 78 Gy). The normal tissue complication probability (NTCP) for each of the 8 scenarios was calculated using the Lyman-Kutcher-Burman model to estimate the risk of rectal and bladder late toxicity. The conformity and homogeneity indices of PTVs were calculated for each plan.

Results: The IMRT plans showed superiority in conformity and inferiority in homogeneity over 3-dimensional CRT plans. The rectal NTCPs were increased 3.5 to 4.1 times when the prescribed total dose was changed from 70 Gy to 78 Gy and the dose delivery and the image guided radiation therapy techniques remained unchanged. PTV margin reduction was shown to reduce the value of rectal NTCP significantly. Overall, implementing the IMRT technique alone could reduce the NTCP values only by 2.1% to 7.3% from those of 3-dimensional CRT. The introduction of both IMRT and PTV margin reduction was found to be necessary for rectal NTCP to remain <5% in the dose escalation from 70 to 78 Gy.

Conclusions: The complementary relationship between the introduction of IMRT and PTV margin reduction was proven. We found that both approaches need to be implemented to safely deliver a curative dose in dose-escalating prostate radiation therapy.

Citing Articles

First-in-Men Online Adaptive Robotic Stereotactic Body Radiation Therapy: Toward Ultrahypofractionation for High-Risk Prostate Cancer Patients.

Brand V, Milder M, Christianen M, de Vries K, Hoogeman M, Incrocci L Adv Radiat Oncol. 2025; 10(2):101701.

PMID: 39866592 PMC: 11758839. DOI: 10.1016/j.adro.2024.101701.


Comparative Study of Eclipse and RayStation Multi-Criteria Optimization-Based Prostate Radiotherapy Treatment Planning Quality.

Wong J, Leung V, Hung R, Ng C Diagnostics (Basel). 2024; 14(5).

PMID: 38472938 PMC: 10931516. DOI: 10.3390/diagnostics14050465.


Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey.

Rowe L, Mandia J, Salerno K, Shankavaram U, Das S, Escorcia F Adv Radiat Oncol. 2022; 7(5):100902.

PMID: 35847548 PMC: 9280021. DOI: 10.1016/j.adro.2022.100902.